Ciprocinonide

DB18738ApprovedWithdrawnSmall molecule

Ciprocinonide: Overview.

Formula / weight: C₂₈H₃₄F₂O₇ · 520.57 g/mol (avg)
First approval: Canada, 1987
Also known as: 6.alpha.,9-difluoro-11.beta.,16.alpha.,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-cyclopropanecarboxylate · 6α,9-Difluoro-11β,16α,17,21-tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with acetone, 21-cyclopropanecarboxylate · Pregna-1,4-diene-3,20-dione, 21-((cyclopropylcarbonyl)oxy)-6,9-difluoro-11-hydroxy-16,17-((1-methylethylidene)bis(oxy))-, (6.alpha.,11.beta.,16.alpha.)-
Code names: RS-2386

Resolves to

Compound

Structure

[H][C@@]12C[C@@]3([H])[C@]4([H])C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]1(OC(C)(C)O2)C(=O)COC(=O)C1CC1

What you can answer from here — as of March 06, 2025

1Marketed productAcross 1 country and 1 labeller

Which companies are running trials of Ciprocinonide, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.